Ossiam Purchases 1,541 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Ossiam lifted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 77.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,541 shares of the medical equipment provider's stock after purchasing an additional 1,541 shares during the quarter. Ossiam's holdings in Align Technology were worth $738,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of ALGN. Picton Mahoney Asset Management increased its position in Align Technology by 69.9% during the 4th quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 58 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new stake in Align Technology during the 4th quarter valued at approximately $31,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Align Technology in the fourth quarter worth $35,000. Private Trust Co. NA raised its stake in shares of Align Technology by 113.4% in the 4th quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 93 shares in the last quarter. Finally, Versant Capital Management Inc lifted its holdings in Align Technology by 212.2% during the 4th quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider's stock worth $48,000 after buying an additional 157 shares during the last quarter. Institutional investors and hedge funds own 88.43% of the company's stock.

Align Technology Stock Performance

Shares of NASDAQ:ALGN traded down $0.92 during midday trading on Friday, hitting $183.35. The company's stock had a trading volume of 1,162,658 shares, compared to its average volume of 886,186. The stock has a market capitalization of $13.42 billion, a price-to-earnings ratio of 32.68, a PEG ratio of 2.24 and a beta of 1.73. Align Technology, Inc. has a fifty-two week low of $141.74 and a fifty-two week high of $327.49. The stock's 50 day simple moving average is $170.38 and its 200 day simple moving average is $203.10.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. As a group, analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ALGN. Needham & Company LLC reissued a "hold" rating on shares of Align Technology in a report on Thursday, February 6th. Evercore ISI increased their price target on Align Technology from $240.00 to $260.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Wells Fargo & Company assumed coverage on shares of Align Technology in a report on Friday, February 14th. They issued an "overweight" rating and a $255.00 target price on the stock. Morgan Stanley dropped their price target on Align Technology from $280.00 to $272.00 and set an "overweight" rating on the stock in a research note on Thursday, February 6th. Finally, Jefferies Financial Group decreased their target price on Align Technology from $285.00 to $260.00 and set a "buy" rating for the company in a research report on Thursday, January 23rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $246.17.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.